Access Resources
3601 - 3610 of 7540 Results
Title
Year
- Two C-terminal sequence variations determine differential neurotoxicity between human and mouse α-synuclein2020RESTRICTEDTitle: Two C-terminal sequence variations determine differential neurotoxicity between human and mouse α-synucleinJournal Name: Molecular NeurodegenerationPublisher: Springer Science and Business Media LLCVol: 15Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1186/s13024-020-00380-wBest OA location URL: https://molecularneurodegeneration.biomedcentral.com/track/pdf/10.1186/s13024-020-00380-wCitation Count: 7
-
RESTRICTEDTitle: Helicobacter pylori Eradication in Parkinson's Disease: A Randomized Placebo‐Controlled TrialJournal Name: Movement DisordersPublisher: WileyVol: 35Issue #: 12Start Page: 2250End Page: 2260Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.28248Citation Count: 45
-
RESTRICTEDTitle: Striatal dopaminergic denervation and hypomimia in Parkinson's diseaseJournal Name: European Journal of NeurologyPublisher: WileyVol: 28Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1111/ene.14483Citation Count: 2
-
RESTRICTEDTitle: When antibodies mislead: the quest for validationJournal Name: NaturePublisher: Springer Science and Business Media LLCVol: 585Issue #: 7824Start Page: 313End Page: 314Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1038/d41586-020-02549-1Citation Count: 26
-
RESTRICTEDTitle: Non-Coding RNAs in the Brain-Heart Axis: The Case of Parkinson’s DiseaseJournal Name: International Journal of Molecular SciencesPublisher: MDPI AGVol: 21Issue #: 18Start Page: 6513End Page: 6513Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3390/ijms21186513Best OA location URL: https://www.mdpi.com/1422-0067/21/18/6513/pdf?version=1599382153Citation Count: 19
- Characterization of Anchorless Human PrP With Q227X Stop Mutation Linked to Gerstmann-Sträussler-Scheinker Syndrome In Vivo and In Vitro2020RESTRICTEDTitle: Characterization of Anchorless Human PrP With Q227X Stop Mutation Linked to Gerstmann-Sträussler-Scheinker Syndrome In Vivo and In VitroJournal Name: Molecular NeurobiologyPublisher: Springer Science and Business Media LLCVol: 58Issue #: 1Start Page: 21End Page: 33Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1007/s12035-020-02098-8Best OA location URL: https://link.springer.com/content/pdf/10.1007/s12035-020-02098-8.pdfCitation Count: 4
-
RESTRICTEDTitle: Longitudinal Measurements of Glucocerebrosidase activity in Parkinson’s patientsJournal Name: Annals of Clinical and Translational NeurologyPublisher: WileyVol: 7Issue #: 10Start Page: 1816End Page: 1830Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/acn3.51164Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/acn3.51164Citation Count: 22
- Progressive Ataxia with Hemiplegic Migraines: a Phenotype of CACNA1A Missense Mutations, Not CAG Repeat Expansions2020RESTRICTEDTitle: Progressive Ataxia with Hemiplegic Migraines: a Phenotype of CACNA1A Missense Mutations, Not CAG Repeat ExpansionsJournal Name: The CerebellumPublisher: Springer Science and Business Media LLCVol: 20Issue #: 1Start Page: 134End Page: 139Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s12311-020-01185-9Citation Count: 3
- In Search of Effective Treatments Targeting α-Synuclein Toxicity in Synucleinopathies: Pros and Cons2020RESTRICTEDTitle: In Search of Effective Treatments Targeting α-Synuclein Toxicity in Synucleinopathies: Pros and ConsJournal Name: Frontiers in Cell and Developmental BiologyPublisher: Frontiers Media SAVol: 8Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3389/fcell.2020.559791Best OA location URL: https://www.frontiersin.org/articles/10.3389/fcell.2020.559791/pdfCitation Count: 14
- A Phase 1 Randomized Trial of Specific Active α‐Synuclein Immunotherapies PD01A and PD03A in Multiple System Atrophy2020RESTRICTEDTitle: A Phase 1 Randomized Trial of Specific Active α‐Synuclein Immunotherapies PD01A and PD03A in Multiple System AtrophyJournal Name: Movement DisordersPublisher: WileyVol: 35Issue #: 11Start Page: 1957End Page: 1965Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/mds.28218Best OA location URL: https://movementdisorders.onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.28218Citation Count: 52